Provided by Tiger Trade Technology Pte. Ltd.

Viking Therapeutics

29.94
-0.5700-1.87%
Post-market: 30.030.0872+0.29%19:59 EDT
Volume:6.37M
Turnover:192.46M
Market Cap:3.49B
PE:-6.41
High:31.09
Open:30.85
Low:29.90
Close:30.51
52wk High:43.15
52wk Low:25.77
Shares:116.65M
Float Shares:110.00M
Volume Ratio:0.72
T/O Rate:5.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.6676
EPS(LYR):-3.1920
ROE:-88.85%
ROA:-51.86%
PB:8.55
PE(LYR):-9.38

Loading ...

Viking Therapeutics Q1 loss widens on  higher research, development expenses

Reuters
·
Apr 30

Viking Therapeutics Q1 EPS $(1.37) Misses $(1.02) Estimate

Benzinga Earnings
·
Apr 30

BRIEF-Viking Therapeutics Q1 EPS USD -1.37 Vs. IBES Estimate USD -1.01

Reuters
·
Apr 30

Viking Therapeutics Q1 EPS USD -1.37 VS. Ibes Estimate USD -1.01

THOMSON REUTERS
·
Apr 30

Viking Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
Apr 30

U.S. Earnings Preview: After Market Close April 29

Dow Jones
·
Apr 30

Viking Therapeutics options imply 7.0% move in share price post-earnings

TIPRANKS
·
Apr 30

Viking Therapeutics Inc expected to post a loss of $1.01 a share - Earnings Preview

Reuters
·
Apr 28

Viking Therapeutics to report first-quarter results, host conference call

Reuters
·
Apr 23

Top Calls on Wall Street: Nvidia, Apple, Tesla, Alphabet, Cava, Netflix, Airbnb, Viking and More

Tiger Newspress
·
Apr 22

Health Care Up After UnitedHealth Earnings -- Health Care Roundup

Dow Jones
·
Apr 22

Viking Therapeutics to attend Raymond James Biotech/BioPharma Conference in investor meetings

Reuters
·
Apr 10

Viking Therapeutics call volume above normal and directionally bullish

TIPRANKS
·
Apr 10

Viking Therapeutics May Benefit From New Era for Weight Loss Pills, Oppenheimer Says

MT Newswires Live
·
Apr 08

Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX) and Terumo (OtherTRUMF)

TIPRANKS
·
Apr 08

A Look At Viking Therapeutics (VKTX) Valuation As VANQUISH 2 Reaches Full Phase 3 Enrollment

Simply Wall St.
·
Apr 08

Viking Therapeutics (VKTX) Is Up 7.0% After Completing Enrollment In Key VANQUISH-2 Obesity Trial

Simply Wall St.
·
Apr 06